idiopathic pulmonary fibrosis patients
Conditions
Interventions
None listed
Sponsors
Dokkyo Medical University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: IPF patients diagnosed based on ATS/ERS/JRS/ALAT
Exclusion criteria
Exclusion criteria: 16 yers <
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify the plasma lipid reflecting IPF pathogenesis | — |
Countries
Japan
Contacts
Public ContactYasuo Shimizu
Dokkyo Medical University School of Medicine Department of Pulmonary Medicine and Clinical Immunology
Outcome results
None listed